Corcept Therapeutics (CORT) Misses Q1 EPS by 5c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $113.05 -3.32%
Financial Fact:
Research and development: 7.05M
Today's EPS Names:
CHA, EDXC, YAYO, More
Financial Fact:
Research and development: 7.05M
Today's EPS Names:
CHA, EDXC, YAYO, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q1 EPS of $0.14, $0.05 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $105.7 million versus the consensus estimate of $104.91 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- Warsh: Inflation Data Don’t Suggest Trend Meaningfully Improved
- Hub Group faces credibility test as Q2 report looms Sept. 1
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
